The European Commission (EC) has approved Biocon Biologics’ biosimilars referencing Amgen’s bone disease therapy denosumab.

Glenmark Pharmaceuticals Ltd.’s licensing pact with AbbVie Inc. for its blood cancer drug is boosting optimism over Indian ...

Bhosale's top pick is Prestige Estates Projects with a stoploss of Rs 1,600. "The stock is looking very positive on the daily ...

Syngene International Ltd., an integrated research, development, and manufacturing services organization, in partnership with ...

We’re now the second source for many products made in China—and the first choice for new ones,” Ajay Bhardwaj, CEO and ...

Syngene, in collaboration with RICH and Biocon Foundation, launched the third cohort of a transformative program for women in ...

Bangalore: Biocon has announced the appointment of Ekta Agarwal as the Interim Company Secretary and Compliance Officer ...

Syngene International, in collaboration with the Research and Innovation Circle of Hyderabad (RICH) and Biocon Foundation, has announced the launch of the third cohort of its flagship women-in-STEM ...

Syngene International Ltd., an integrated research, development, and manufacturing services organization, in partnership with the Research and Innovation Circle of Hyderabad (RICH) and Biocon ...

Several pharma stocks, including Laurus Labs, Lupin, Biocon, Cipla and Divi's Labs, rose up to 3 per cent in the morning session, pushing their sectoral index, Nifty Pharma, higher by about half a per ...

Syngene International Ltd., an integrated research, development, and manufacturing services organization, in partnership with ...

Thwarted in her ambition to become a brewmaster, Kiran Mazumdar-Shaw channeled her frustrations into building an ...